Outcome of Board Meeting
METROPOLIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Metropolis Healthcare reported strong FY2026 results with consolidated revenue of Rs 1,64,585 lakhs (up 23.6% YoY) and PAT of Rs 19,118 lakhs (up 31.4% YoY). The Board declared a 2nd interim dividend of Rs 1 per share (record date May 19, 2026). Statutory auditors B S R & Co. LLP completed their term and Deloitte Haskins & Sells has been recommended for appointment for 5 years. Dr. Nilesh Shah transitions from President - Internal Assurance to advisory role effective May 14, 2026. The audit received an unmodified (clean) opinion. Exceptional items of Rs 899 lakhs were recorded primarily due to statutory impact of new Labour Codes. The company also faces a reduced income tax demand of Rs 3,880 lakhs pending ITAT appeal.
Strong financial performance with robust revenue and profit growth signals healthy business momentum. The auditor change is routine after completion of term. Dividend declaration provides shareholder returns. The income tax matter remains a contingent liability but has been reduced from original demand.